This inventor holds 2 USPTO granted patents. Top assignee: Asta Medica, Aktiengesellschaft. Active years: 1997-1998.
Company Filing History:
Years Active: 1997-1998
Title: Innovations in Erythrocyte Viability: The Work of Wolfgang Geise
Introduction
Wolfgang Geise, an accomplished inventor located in Dipbach, Germany, is renowned for his significant contributions to the field of biomedical innovation. With a total of two patents to his name, Geise has focused on enhancing the viability and properties of stored erythrocytes, which are crucial for medical treatments.
Latest Patents
His latest patents detail methods for increasing the viability of stored erythrocytes. One of his notable inventions involves the use of D,L-alpha-lipoic acid and its enantiomers or derivatives for improving the oxygen release capacity, viscoelasticity, and erythrocyte aggregability during storage. These treatments also enhance the resistance to membrane peroxidation during storage and mitigate damage caused by the freeze/thaw process. Furthermore, his inventions propose the use of alpha-lipoic acid in treating disorders associated with the rheological properties of blood, particularly for conditions like microangiopathy, circulatory disturbances, and protection of erythrocytes in diabetic and dialysis patients.
Career Highlights
Wolfgang Geise is currently associated with Asta Medica Aktiengesellschaft, where his pioneering work continues to advance the field of hematology. His research emphasizes the importance of erythrocyte flexibility and the prevention of blood viscosity issues, which can have significant implications for patient care.
Collaborations
Geise's efforts are further strengthened through collaborations with esteemed colleagues such as Frank Conrad and Hermann-August Henrich. Their combined expertise contributes to innovative solutions in the treatment of blood-related ailments and improves patient outcomes.
Conclusion
Wolfgang Geise's dedication to innovation in the medical field showcases the impact that well-researched inventions can have on patient care and treatment methodologies. His work in improving erythrocyte viability not only pushes the boundaries of current scientific understanding but also opens new avenues for addressing critical health issues.